-
2024-514904-14-00
4
2014-10-08
Patients with metastatic or unresectable locally advanced malignancies
-
2024-511096-15-00
5
2014-08-01
Breast Cancer
-
2024-517622-25-00
5
2013-12-06
Patients with localized prostate cancer and high-risk features of rela
-
2024-516996-34-00
5
2012-04-12
oestrogen-receptor (ER)-positive HER2-negative breast carcinoma
-
2024-514844-10-00
4
2010-03-18
Retinoblastoma
-
2024-516687-28-00
5
2025-06-06
Patients with GPA and inadequate response to standard of care therapy
-
2023-510559-41-00
4
2025-01-02
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
-
2024-515994-83-00
5
2026-01-13
aneurysmal subarachnoid hemorrhage with a vasospasm
-
2024-513697-22-00
5
2024-11-07
non-small-cell lung cancer
-
2024-513648-27-00
4
2024-10-25
Patients with newly or active diffuse Systemic sclerosis (SSc) at the
-
2023-508216-29-00
5
2024-10-14
Dental care
-
2024-511363-28-00
5
2024-09-24
hidradenitis suppurativa (HS)
-
2024-511225-64-00
4
2024-09-18
Alopecia areata
-
2023-509001-76-00
5
2024-07-01
Asthma
-
2023-509336-25-00
9
2024-06-12
Metastatic castration-resistant prostate cancer
-
2023-505022-34-00
4
2024-03-27
Neoplasm malignant
-
2023-505543-39-00
5
2024-02-12
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-503315-15-00
4
2023-12-20
Thrombolysis of symptomatic proximal vein thrombosis
-
2022-502372-22-01
4
2023-10-19
Metastatic Breast Cancer HR+, HER2-
-
2022-501621-20-00
5
2023-10-02
Prurigo Nodularis
-
2022-501752-29-00
5
2023-06-15
Hidradenitis Suppurativa
-
2023-508163-74-00
5
2023-06-12
Major Depressive Disorder
-
2022-501078-20-00
4
2023-05-15
Metastatic Castration-resistant Prostate Cancer
-
2022-501586-50-00
5
2023-05-15
Atopic Dermatitis